Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 107
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01905059 | Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa | ||
| NCT03696160 | The Late Presenter Treatment Optimisation Study | ||
| NCT02987829 | Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients | ||
| NCT05109559 | Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine | ||
| NCT02307864 | Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants | ||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | ||
| NCT01376401 | Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma | ||
| NCT01241760 | VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection | ||
| NCT03475628 | Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma | ||
| NCT04983030 | Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults | ||
| NCT03522259 | Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery | ||
| NCT05619536 | Study of CD388 Subcutaneous Administration in Healthy Japanese Subjects | ||
| NCT02373930 | Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects | ||
| NCT04399551 | A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries | ||
| NCT03823924 | Changes in Body Composition Under Ustekinumab in PsA | ||
| NCT02867020 | Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels | ||
| NCT03503344 | Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer | ||
| NCT03939182 | Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma | ||
| NCT01848028 | PsoBest - The German Psoriasis Registry | ||
| NCT02745054 | Safety of Oral Anticoagulants Registry | ||
| NCT02756247 | A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma | ||
| NCT03586570 | A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects | ||
| NCT03290950 | A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT00001018 | A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea | ||
| NCT00959894 | Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection | ||
| NCT00140426 | A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa | ||
| NCT01641367 | A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure | ||
| NCT05304858 | Tumor Microenvironment Analysis of Prostate Cancer Metastasis | ||
| NCT06358638 | Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody | ||
| NCT03450057 | Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment | ||
| NCT02438631 | Placental Passage and Disposition of Drugs: A Physiology-based Approach | ||
| NCT04240210 | Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) | ||
| NCT04162366 | A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease. | ||
| NCT06066346 | A Study of Talquetamab for People with Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy | ||
| NCT00006371 | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer | ||
| NCT06232551 | Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism | ||
| NCT04394936 | An Explorative Psoriasis Biomarker Study | ||
| NCT07110844 | Teclistamab-Daratumumab in AL Amyloidosis | ||
| NCT02951052 | Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults | ||
| NCT02429791 | Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1) | ||
| NCT03993847 | CLassification of Axial SpondyloarthritiS Inception Cohort | ||
| NCT03556332 | A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation | ||
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients | ||
| NCT06083922 | A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) | ||
| NCT00215241 | Risperidone Augmentation for PTSD | ||
| NCT05629052 | TrEatment Approach in the Multimodal Era Registry | ||
| NCT02800928 | Does CERC-501 Attenuate Stress-precipitated Smoking Lapse? | ||
| NCT01717053 | Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer | ||
| NCT03283917 | Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis | ||
| NCT02838693 | Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes) |
